Sanara MedTech Inc. (SMTI)
NASDAQ: SMTI · Real-Time Price · USD
18.66
-0.96 (-4.89%)
At close: Mar 18, 2026, 4:00 PM EDT
19.00
+0.34 (1.82%)
After-hours: Mar 18, 2026, 6:20 PM EDT
Sanara MedTech Revenue
Sanara MedTech had revenue of $26.33M in the quarter ending September 30, 2025, with 21.51% growth. This brings the company's revenue in the last twelve months to $101.90M, up 30.55% year-over-year. In the year 2024, Sanara MedTech had annual revenue of $86.67M with 33.36% growth.
Revenue (ttm)
$101.90M
Revenue Growth
+30.55%
P/S Ratio
1.64
Revenue / Employee
$722,536
Employees
141
Market Cap
166.74M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 86.67M | 21.68M | 33.36% |
| Dec 31, 2023 | 64.99M | 19.15M | 41.77% |
| Dec 31, 2022 | 45.84M | 21.70M | 89.87% |
| Dec 31, 2021 | 24.14M | 8.56M | 54.90% |
| Dec 31, 2020 | 15.59M | 3.82M | 32.47% |
| Dec 31, 2019 | 11.77M | 8.76M | 291.40% |
| Dec 31, 2018 | 3.01M | -2.77M | -47.93% |
| Sep 30, 2018 | 5.77M | -531.19K | -8.43% |
| Dec 31, 2017 | 6.30M | 796.89K | 14.47% |
| Dec 31, 2016 | 5.51M | 2.14M | 63.33% |
| Dec 31, 2015 | 3.37M | 739.55K | 28.09% |
| Dec 31, 2014 | 2.63M | 906.25K | 52.49% |
| Dec 31, 2013 | 1.73M | 552.85K | 47.11% |
| Dec 31, 2012 | 1.17M | -1.04M | -46.89% |
| Dec 31, 2011 | 2.21M | 1.30M | 142.71% |
| Dec 31, 2010 | 910.42K | 622.40K | 216.10% |
| Dec 31, 2009 | 288.02K | -2.16K | -0.75% |
| Dec 31, 2008 | 290.18K | -340.32K | -53.98% |
| Dec 31, 2007 | 630.51K | 440.75K | 232.27% |
| Dec 31, 2006 | 189.76K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AngioDynamics | 307.31M |
| OraSure Technologies | 115.02M |
| Harvard Bioscience | 86.55M |
| Pro-Dex | 72.10M |
| KORU Medical Systems | 41.13M |
| Utah Medical Products | 38.52M |
| Stereotaxis | 32.38M |
| Nyxoah | 6.62M |
SMTI News
- 7 days ago - Sanara MedTech Inc. Announces Publication of Peer-Reviewed Study Evaluating the Economic and Clinical Value of CellerateRX® Surgical Powder in the Management of Spine Surgery Wounds - GlobeNewsWire
- 15 days ago - Sanara MedTech Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026 - GlobeNewsWire
- 4 weeks ago - Sanara MedTech Inc. to Participate in the TD Cowen 46th Annual Health Care Conference on March 3rd - GlobeNewsWire
- 7 weeks ago - Sanara MedTech Inc. Reports Unaudited Preliminary Financial Results for the Fourth Quarter and Full Year 2025; Introduces Full Year 2026 Financial Guidance - GlobeNewsWire
- 2 months ago - Sanara MedTech Inc. Receives Innovative Technology Contract from Vizient for BIASURGE® Advanced Surgical Solution - GlobeNewsWire
- 3 months ago - Sanara MedTech Inc. and Biomimetic Innovations Provide Update on OsStic™ - GlobeNewsWire
- 3 months ago - Sanara MedTech: Too Cheap And Better Positioned After Earlier Strategic Missteps - Seeking Alpha
- 4 months ago - Sanara MedTech to Participate in the Piper Sandler 37th Annual Healthcare Conference on December 3rd - GlobeNewsWire